These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 30559986)

  • 21. Medicare and state health care programs: fraud and abuse, civil money penalties and intermediate sanctions for certain violations by health maintenance organizations and competitive medical plans--HHS. Correction to final regulations.
    Fed Regist; 1994 Sep; 59(183):48566-8. PubMed ID: 10137643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Canadian Natural Health Products (NHP) regulations: industry perceptions and compliance factors.
    Laeeque H; Boon H; Kachan N; Cohen JC; D'Cruz J
    BMC Health Serv Res; 2006 May; 6():63. PubMed ID: 16734916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do We Need Stronger Sanctions to Ensure Legal Compliance By Pharmaceutical Firms?
    Rodwin MA
    Food Drug Law J; 2015; 70(3):435-52, ii. PubMed ID: 26630824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Criminal justice outcomes for cannabis use offences in New Zealand, 1991-2008.
    Wilkins C; Sweetsur P
    Int J Drug Policy; 2012 Nov; 23(6):505-11. PubMed ID: 22521268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New exclusions and penalties complicate compliance programs.
    Fedor FP; Fuhrman CJ
    Healthc Financ Manage; 1998 Dec; 52(12):56-60. PubMed ID: 10338799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic review: work-related stress and the HSE management standards.
    Brookes K; Limbert C; Deacy C; O'Reilly A; Scott S; Thirlaway K
    Occup Med (Lond); 2013 Oct; 63(7):463-72. PubMed ID: 23847137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety teams. Government and business organizations want them and use them, but are they legal?
    Muscatello JR; Heshizer BP
    J Safety Res; 2002; 33(1):21-32. PubMed ID: 11979635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Canadian Natural Health Products (NHP) regulations: industry compliance motivations.
    Laeeque H; Boon H; Kachan N; Cohen JC; D'Cruz J
    Evid Based Complement Alternat Med; 2007 Jun; 4(2):257-62. PubMed ID: 17549245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medicare and Medicaid fraud and abuse regulations.
    Liang FZ; Black BL
    Am J Hosp Pharm; 1991 Nov; 48(11):2434-7. PubMed ID: 1746579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, 'legal highs')? Implications for law enforcement and penalties.
    Rychert M; Wilkins C
    Drug Test Anal; 2016 Aug; 8(8):768-78. PubMed ID: 26857892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penalties for health care fraud and abuse: January 2007-March 2008.
    Shah UK; Johnston DR; Smith GM; Ziv BE; Reilly JS
    Otolaryngol Head Neck Surg; 2009 May; 140(5):625-8. PubMed ID: 19393400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IRS issues new disclosure rules for tax-exempt organizations.
    Luecke RW; Shortill KJ
    Healthc Financ Manage; 1999 Dec; 53(12):52-4. PubMed ID: 11066696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Moving towards a better path? A mixed-method examination of China's reforms to remedy medical corruption from pharmaceutical firms.
    Shi J; Liu R; Jiang H; Wang C; Xiao Y; Liu N; Wang Z; Shi L
    BMJ Open; 2018 Feb; 8(2):e018513. PubMed ID: 29439069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Perception of Occupational Safety and Health (OSH) Regulation and Innovation Efficiency in the Construction Industry: Evidence from South Korea.
    Shin J; Kim Y; Kim C
    Int J Environ Res Public Health; 2021 Feb; 18(5):. PubMed ID: 33673463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On-Demand Telemedicine as a Disruptive Health Technology: Qualitative Study Exploring Emerging Business Models and Strategies Among Early Adopter Organizations in the United States.
    Sterling R; LeRouge C
    J Med Internet Res; 2019 Nov; 21(11):e14304. PubMed ID: 31730038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health and safety in the NHS.
    Griffith R
    Br J Nurs; 2014 Jan 23-Feb 12; 23(2):112-3. PubMed ID: 24464118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mobile Messaging Communication in Health Care: Rules, Regulations, Penalties, and Safety of Provider Use.
    Balch Samora J; Blazar PE; Lifchez SD; Bal BS; Drolet BC
    JBJS Rev; 2018 Mar; 6(3):e4. PubMed ID: 29557794
    [No Abstract]   [Full Text] [Related]  

  • 39. Priority-setting in public health research funding organisations: an exploratory qualitative study among five high-profile funders.
    Cartier Y; Creatore MI; Hoffman SJ; Potvin L
    Health Res Policy Syst; 2018 Jun; 16(1):53. PubMed ID: 29933748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Will Medicare Readmission Penalties Motivate Hospitals to Reduce Arthroplasty Readmissions?
    Clement RC; Gray CM; Kheir MM; Derman PB; Speck RM; Levin LS; Fleisher LA
    J Arthroplasty; 2017 Mar; 32(3):709-713. PubMed ID: 27712937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.